{"id":"W2765131124","doi":"10.25251/skin.2.supp.54","title":"Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study","year":2018,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada; European Academy of Allergy and Clinical Immunology","keywords":"Medicine; Chronic urticaria; Omalizumab; Dermatology; Primary care; Immunology; Immunoglobulin E; Antibody; Family medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001021545,0.0003393616,0.001273051,0.0002453299,0.0001722546,0.00000524808,0.0005443678,0.0001779616,0.000072998],"category_scores_gemma":[0.0008590728,0.0001503361,0.0003107101,0.0006792409,0.001156098,0.00006628292,0.0001112986,0.0006885854,0.000001996097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003728656,"about_ca_system_score_gemma":0.0007374072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001077752,"about_ca_topic_score_gemma":0.0000487276,"domain_scores_codex":[0.9950935,0.0004706659,0.002011495,0.0002418496,0.001804285,0.0003782188],"domain_scores_gemma":[0.9951639,0.0005692152,0.001810467,0.001057965,0.001200493,0.0001979836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1878002,0.02876003,0.260639,0.001127782,0.1354102,0.02666925,0.1503263,0.0014433,0.1888491,0.000848964,0.003664108,0.01446181],"study_design_scores_gemma":[0.09911314,0.2656878,0.3371435,0.0218755,0.174307,0.06001182,0.01122098,0.0009507831,0.02740437,0.0009658171,0.0003103681,0.001008955],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993935,0.001397229,0.00005574955,0.001161514,0.0007266892,0.001164271,0.00002496721,0.00001315809,0.001521457],"genre_scores_gemma":[0.9990146,0.0001374512,0.0001324099,0.00007732818,0.0003966182,0.000003714465,0.00000814828,0.00004678777,0.0001829857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2369278,"threshold_uncertainty_score":0.613053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005904810974161413,"score_gpt":0.2346256141413623,"score_spread":0.2287208031672009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}